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Background: This preliminary study reports the ﬁrst docu-
mented evidence of antimalarial drug resistance polymorphisms
in South Eastern Nigeria.
Methods & Materials: Real Time PCR (RT-PCR) assay was used
to type for pfmdr1 genes whereas pfdhfr, pfdhps and pfcrt genes
were typed with the Restriction Fragment Length Polymorphism
of PCR(PCR-RTLP) from blood spots of two hundred under ﬁve
children attending pediatric clinics in the Federal Medical Centre,
Owerri, South Eastern Nigeria.
Results: Treatment with antimalarial drug in the last two days
was reported by 10.3% of the children. Antimalaria drug resistance
mutations were detected in all the samples with pfdhfr S108T(76%)
and pfdhpsA438G(72%) recording the highest prevalence.Mutation
in the pfcrt gene however was only detected in 43% of the samples.
Mixed polymorphisms were observed more in triple mutations of
pfdhps (69%) and pfdhfr (64%) respectivelywhile quintuple and sex-
tuple mutations accounted for 20% and 32% respectively.
Conclusion: These results ascertain the prevalence of anti-
malarial drug resistance polymorphisms in South Eastern Nigeria
with their changing patterns of occurrence. This may form a base-
line for the continuous monitoring of drug resistance in South
Eastern Nigeria to inform more effective and sustainable planning
and implementation of evidence based antimalarial drug policies.
http://dx.doi.org/10.1016/j.ijid.2014.03.774
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Diagnosing female genital schistosomiasis
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Background: Almost 100 million women in Sub-Saharan Africa
are thought to be at risk of female genital schistosomiasis. It is
manifested by genital lesions, causes pain, discharge and possi-
bly increased risk of HIV transmission. There is currently no gold
standard for diagnosing FGS. Urine diagnostics (PCR/microscopy
of urine, haematuria, CAA, and antibodies) are nonspeciﬁc and
insensitive predictors of genital pathology. Biopsy of lesions with
detection of ova by microscopy may conﬁrm positive cases. How-
ever, FGS is largely co-endemic with HIV, rendering this approach
unethical, as the iatrogenic lesion may increase the risk of HIV
transmission. The characteristic yellow lesionsmay serve as a diag-
nosiswhenvisualisedbya trainedexpertwho isusinga colposcope.
However, objective and simple diagnostic tools are needed.
Methods & Materials: Women from an endemic area were
recruited for gynaecological examinations with colposcopy. Sam-
ples were collected for schistosomiasis PCR, urine microscopy and
STI analyses. Computer colour analysis was applied on colposcopic
data to identify yellow lesions. The state of the art diagnosis for S.
haematobium diagnosis will be presented.
Results:Wefounda strongassociationbetween theoutput from
thecomputer colouranalysis and theexpert FGSdiagnosis (adjuste-
dOR 6.51, 95% CI 2.56 - 16.56, p <0.001). Likewise, the computer
colour analysis was associated with urinary Schistosoma haema-
tobium (OR 3.52, 95% CI 1.50- 8.27, p =0.004). In the absence of
a gold standard we applied latent class analysis (LCA). We used
data from six variables: computer image analysis, clinical ﬁndings,
microscopy of urine, PCRs in cervico-vaginal lavage and urine, and
school prevalence. We found that computer colour analysis may
yielda sensitivityof80.5%andaspeciﬁcityof65.4% for thediagnosis
of FGS.
Conclusion: A computerised tool for automated detection of
lesions may be of help to the clinician, offering an objective assess-
ment of lesions. This software could be used in simple electronic
devices, in rural, endemic areas as a point of care diagnosis. Fur-
ther research is needed on the texture and shape of the lesions to
improve the performance and to explore how this could bemerged
with the imminent technology for cancer screening.
http://dx.doi.org/10.1016/j.ijid.2014.03.775
